| Cost-effectiveness of community-based treatment of severe acute malnutrition in children. | |
| | |
MedLine Citation:
|
PMID: 20950075 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Severe acute malnutrition affects 20 million children aged under 5 years old worldwide. Medical complications and death are common, but nutritional and medical treatment can result in good outcomes. Randomized trials of treatment after in-patient stabilization have shown community-based treatment to have similar outcomes to hospital-based treatment, at lower cost. Community-based ambulatory treatment, with in-patient care reserved for the most severe cases, is increasingly being implemented in Africa but has not been evaluated in randomized trials. Community-based treatment programs have shown favorable outcomes. Economic evaluations of community-based treatment have included cost analyses, cost and consequence analyses and decision analyses. Treatment costs have been consistently lower than for institution-based treatment. Costs of ambulatory community-based treatment of severe acute malnutrition have ranged between US$46 to $453 per child, depending on the type of care provided and the costing methods used. Recent studies have reported on costs and outcomes of similar large-scale African programs covering geographically defined populations, with ambulatory care for most children, and initial in-patient stabilization for the minority with most severe disease. In these studies the costs ranged from US$129 to $201 per child, and mortality rates ranged from 1.2 to 9.2%, depending on length of follow-up. A decision tree model based on such a program in Zambia estimated that community-based treatment of severe acute malnutrition in primary-care centers, with hospital access, cost US$203 per case treated, US$1760 per life saved, and US$53 per disability-adjusted life year gained, compared with no treatment. This latter cost per disability-adjusted life year gained suggests that community-based treatment of severe acute malnutrition is cost effective compared with other priority health interventions in low-income countries, and compared with such countries' national incomes. |
| | |
Authors:
|
Max Oscar Bachmann |
Related Documents
:
|
3679625 - Similarity of behavior within addict couples. part i. methodology and narcotics patterns. 11135505 - A mandatory short-term methadone-to-abstinence program in new york city. 1918745 - Weight loss programs: failing to meet ethical standards? 707615 - Wilderness camping: an evaluation of a residential treatment program for emotionally di... 152585 - Stigmatization of carrier status: social implications of heterozygote genetic screening... 15181595 - Veterinary school admission interviews, part 3: strategies for increasing interview val... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Expert review of pharmacoeconomics & outcomes research Volume: 10 ISSN: 1744-8379 ISO Abbreviation: Expert Rev Pharmacoecon Outcomes Res Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-18 Completed Date: 2011-01-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101132257 Medline TA: Expert Rev Pharmacoecon Outcomes Res Country: England |
Other Details:
|
Languages: eng Pagination: 605-12 Citation Subset: IM |
Affiliation:
|
Medical School, University of East Anglia, Norwich NR4 7TJ, UK. m.bachmann@uea.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Africa / epidemiology Ambulatory Care / economics*, methods Child Nutrition Disorders / economics, epidemiology, therapy* Child, Preschool Community Health Services / economics*, methods Cost-Benefit Analysis Decision Trees Developing Countries Humans Quality-Adjusted Life Years Randomized Controlled Trials as Topic Severity of Illness Index |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Walking speed and economic outcomes for walking-impaired patients with multiple sclerosis.
Next Document: Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children.